Related Experiment Video
Updated: Apr 15, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
The Interplay Between Periodontitis and Atrial Fibrillation: Inflammation as a Common Pathophysiological Bridge
Francesco Caprino1, Andrea Filardo2, Jessica Bria2
1Department of Experimental and Clinical Medicine, University Magna Græcia, 88100 Catanzaro, Italy.
None:
Periodontitis (PD) and atrial fibrillation (AF) are two prevalent chronic conditions with substantial public health burdens worldwide. While traditionally studied separately, increasing evidence reveals a complex interplay between PD and AF, mediated primarily by shared inflammatory and immune mechanisms. Chronic periodontal inflammation can trigger systemic immune activation, leading to atrial structural remodeling, fibrosis, and electrical disturbances that predispose individuals to AF. Observational and longitudinal studies consistently demonstrate a higher incidence and recurrence of AF in patients with moderate to severe PD, independent of established cardiovascular risk factors. Key periodontal pathogens, especially Porphyromonas gingivalis, and altered immune cell profiles are implicated in this association, further supported by genetic analyses revealing common molecular pathways. Mechanistic insights from experimental models highlight the role of inflammation-related atrial fibrosis and immune dysregulation as critical drivers linking oral disease to arrhythmogenesis. Additionally, better oral hygiene practices and periodontal treatment have been associated with a reduced risk of AF, suggesting modifiable intervention potential. This review synthesizes current clinical, epidemiological, molecular, and experimental evidence to elucidate the PD-AF relationship, emphasizing periodontal health as a promising target in cardiovascular disease prevention strategies.
Related Concept Videos
The Oral Microbiota
Rheumatic Heart Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Endocarditis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Atherosclerosis I: Introduction

